Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 1, 2018
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
Lars Erik Kristensen, Rieke Alten, Luis Puig, et al.
Journal of the American Academy of Dermatology
|
March 15, 2017
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study
Kim Papp, Herve Bachelez, Antonio Costanzo, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 21, 2019
Fluorescence optical imaging for the detection of potential psoriatic arthritis in comparison to musculoskeletal ultrasound
Magdalena Erdmann-Keding, Sarah Ohrndorf, Stephanie Gabriele Werner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 21, 2019
Magdalena Erdmann-Keding, Sarah Ohrndorf, Stephanie Gabriele Werner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 24, 2016
S1-Leitlinie zur Diagnostik und Therapie der Skabies - Kurzfassung
Cord Sunderkötter, Hermann Feldmeier, Regina Fölster-Holst, et al.
Archives of Dermatological Research
|
February 5, 2013
Recommendations for detection of individual risk for comorbidities in patients with psoriasis
Johannes Wohlrab, Gabriele Fiedler, Sascha Gerdes, et al.
Science Translational Medicine
|
September 27, 2013
IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis
Kerstin Wolk, Katrin Witte, Ellen Witte, et al.
European Journal of Immunology
|
October 16, 2009
The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis
Kerstin Wolk, Ellen Witte, Katarzyna Warszawska, et al.
Archives of Dermatological Research
|
December 20, 2005
Pan-selectin antagonism improves psoriasis manifestation in mice and man
Markus Friedrich, Daniel Bock, Sandra Philipp, et al.
Journal of the American Academy of Dermatology
|
August 12, 2015
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study
Ian Landells, Colleen Marano, Ming-Chun Hsu, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
October 1, 2018
Non-pharmacological Effects in Switching Medication: The Nocebo Effect in Switching from Originator to Biosimilar Agent
Lars Erik Kristensen, Rieke Alten, Luis Puig, et al.
Journal of the American Academy of Dermatology
|
March 15, 2017
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study
Kim Papp, Herve Bachelez, Antonio Costanzo, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 21, 2019
Fluorescence optical imaging for the detection of potential psoriatic arthritis in comparison to musculoskeletal ultrasound
Magdalena Erdmann-Keding, Sarah Ohrndorf, Stephanie Gabriele Werner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
September 21, 2019
Magdalena Erdmann-Keding, Sarah Ohrndorf, Stephanie Gabriele Werner, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
November 24, 2016
S1-Leitlinie zur Diagnostik und Therapie der Skabies - Kurzfassung
Cord Sunderkötter, Hermann Feldmeier, Regina Fölster-Holst, et al.
Archives of Dermatological Research
|
February 5, 2013
Recommendations for detection of individual risk for comorbidities in patients with psoriasis
Johannes Wohlrab, Gabriele Fiedler, Sascha Gerdes, et al.
Science Translational Medicine
|
September 27, 2013
IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis
Kerstin Wolk, Katrin Witte, Ellen Witte, et al.
European Journal of Immunology
|
October 16, 2009
The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis
Kerstin Wolk, Ellen Witte, Katarzyna Warszawska, et al.
Archives of Dermatological Research
|
December 20, 2005
Pan-selectin antagonism improves psoriasis manifestation in mice and man
Markus Friedrich, Daniel Bock, Sandra Philipp, et al.
Journal of the American Academy of Dermatology
|
August 12, 2015
Ustekinumab in adolescent patients age 12 to 17 years with moderate-to-severe plaque psoriasis: results of the randomized phase 3 CADMUS study
Ian Landells, Colleen Marano, Ming-Chun Hsu, et al.
Page
of 7